Literature DB >> 11559861

A framework for considering the ethical aspects of psychiatric research protocols.

L W Roberts1, C M Geppert, J L Brody.   

Abstract

The ethics of psychiatric research has emerged as a topic of national importance. Attention to this topic has been stimulated by a number of factors, including heightened awareness of the distinct moral problems arising in the care of mental illness, the rapid development of new psychopharmaceutical agents, the emergence of evidence-based approaches in psychiatry, the expansion of clinical trials within the private mental health sector, and recent recommendations offered by the President's National Bioethics Advisory Commission (NBAC). Consequently, clinical practitioners and investigators alike will increasingly be called upon to evaluate the ethical acceptability of psychiatric research protocols encountered in their professional work. In light of this, we present a framework for considering ethical aspects of psychiatric research protocols. This framework gives emphasis to nine elements: (1) scientific issues; (2) research team issues; (3) risk and benefit in protocol design; (4) confidentiality; (5) selection, exclusion, and recruitment considerations; (6) informed consent and decisional capacity; (7) incentives; (8) institutional and peer/professional review issues; and (9) data presentation issues. Case illustrations are provided. It is hoped that enhanced knowledge of the considerations presented in this framework will ultimately improve our ability to help people with mental illness. Copyright 2001 by W.B. Saunders Company

Entities:  

Keywords:  Biomedical and Behavioral Research; Mental Health Therapies

Mesh:

Year:  2001        PMID: 11559861     DOI: 10.1053/comp.2001.26269

Source DB:  PubMed          Journal:  Compr Psychiatry        ISSN: 0010-440X            Impact factor:   3.735


  7 in total

Review 1.  Beyond the question of placebo controls: ethical issues in psychopharmacological drug studies.

Authors:  Ellen Frank; Danielle M Novick; David J Kupfer
Journal:  Psychopharmacology (Berl)       Date:  2003-04-30       Impact factor: 4.530

2.  A time of promise, a time of promises: ethical issues in advancing psychopharmacological research.

Authors:  Laura Weiss Roberts; John Krystal
Journal:  Psychopharmacology (Berl)       Date:  2003-11-13       Impact factor: 4.530

Review 3.  Emerging empirical evidence on the ethics of schizophrenia research.

Authors:  Laura B Dunn; Philip J Candilis; Laura Weiss Roberts
Journal:  Schizophr Bull       Date:  2005-10-19       Impact factor: 9.306

4.  Views of people with schizophrenia regarding aspects of research: study size and funding sources.

Authors:  Laura Weiss Roberts; Teddy D Warner; Katherine Green Hammond; Jinger G Hoop
Journal:  Schizophr Bull       Date:  2005-10-27       Impact factor: 9.306

5.  Mental Health Research in Correctional Settings: Perceptions of Risk and Vulnerabilities.

Authors:  Mark E Johnson; Karli K Kondo; Christiane Brems; Erica F Ironside; Gloria D Eldridge
Journal:  Ethics Behav       Date:  2015-02-19

Review 6.  Curricular approaches to research ethics training for psychiatric investigators.

Authors:  Donna T Chen
Journal:  Psychopharmacology (Berl)       Date:  2003-05-27       Impact factor: 4.530

7.  Incorporating ethical principles into clinical research protocols: a tool for protocol writers and ethics committees.

Authors:  Rebecca H Li; Mary C Wacholtz; Mark Barnes; Liam Boggs; Susan Callery-D'Amico; Amy Davis; Alla Digilova; David Forster; Kate Heffernan; Maeve Luthin; Holly Fernandez Lynch; Lindsay McNair; Jennifer E Miller; Jacquelyn Murphy; Luann Van Campen; Mark Wilenzick; Delia Wolf; Cris Woolston; Carmen Aldinger; Barbara E Bierer
Journal:  J Med Ethics       Date:  2016-01-25       Impact factor: 2.903

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.